Ayurvedic formulations are recognized to be very effective and to have few adverse effects; yet, there is a gap in the global market for Ayurvedic formulations since there are no validation requirements for identification and quality control. Saraswata Churna is a traditional Ayurvedic concoction used to treat memory loss, psychosomatic illnesses, and other conditions. The goal of the project is to create and standardize Saraswata Churna in accordance with the GMP requirements of the World Health Organization (WHO), which are the first reports of their kind to be made public. The formulation was made at the Shri Krishna Govt. Ayurvedic College and Hospital, Kurukshetra, Haryana, and it was assessed using High Performance Thin Layer Chromatography, powder drug studies, physicochemical parameters (loss in drying, ash value, acid soluble extract, water soluble extract, pH value), and organoleptic characteristics. Powder drug analysis revealed specific identities for crude raw drug, which are useful as markers in the preparation and identification of formulation components. The results of different standardization parameters revealed satisfactory and sufficient data to evaluate the in-house formulation and can be utilized as reference standards in various quality control aspects of the formulation.